Gabriel-Cerberus plans to hike Leumi stake to 20%

Bank of Israel Governor Stanley Fischer praised the deal as putting an end to more than 20 years of state ownership in Israel's banking system.

January 5, 2006 06:53
3 minute read.
leumi logo 88

leumi logo 88. (photo credit: )


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Barnea, the US-based Gabriel-Cerberus consortium has "every intention" of going through with the purchase of the 10.1 percent option provided for in the tender for the purchase of Bank Leumi. "We have 18 months, but I would like to do it as fast as possible," said J. Ezra Merkin, managing partner of the Gabriel Capital Group, which won the tender in November, together with Dan Quayle's Cerberus Capital Management. Merkin spoke following a Prime Minister's Office ceremony Wednesday marking the transfer of Bank Leumi shares from state to private hands. The consortium offered NIS 2.47b. for 9.99% of Bank Leumi, far beyond what the state expected to receive for the asset, significantly boosting the bank's market value. The purchase of the added 10.1% stake, which would give Gabriel-Cerberus a 20% controlling interest in the bank, is awaiting regulatory approval. Invoking the Hanukka motto "a great miracle happened here," Merkin told those gathered that his group sees Bank Leumi as "the flagship bank, perhaps the flagship company, of Israel" as well as an asset of Am Yisrael - "not just another bank in another country." Merkin also stressed the general importance of long-term investments in Israel to his firm. "The well-being of Israel is no small matter for my partners and me," he said. Finance and Industry, Trade and Labor Minister Ehud Olmert said the group's purchase should not only be seen as an investment in Bank Leumi itself, "but also as an investment in the State of Israel and in the economy of Israel," that will encourage others to examine prospective investments in the country. "It is an important day for the Israeli economy that investors like yourselves are coming to invest in Israel. Your investment is a statement of confidence in the Israeli economy and in the opportunity to do successful business in Israel. We are very happy that people of your caliber will now be a part of the economy of Israel," Olmert said. Bank of Israel Governor Stanley Fischer praised the deal as putting an end to more than 20 years of state ownership in Israel's banking system, and said lessons to be learned from "this sad and expensive occurrence" are the need to regulate the banks and keep inflation low since, "without the hyper-inflation of 20 years ago, none of this would have happened." Prime Minister Ariel Sharon said he never doubted the state would be able to sell the bank. "I believed from the beginning that the right path would be to sell off the controlling stake. Even when there were doubts about whether there would be buyers, I had full confidence ... and great belief in our ability to privatize the controlling stake instead of distributing options," he said.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection